First‐line treatment of double‐hit and triple‐hit lymphomas: Survival and tolerance data from a retrospective multicenter French study
2020 · American Journal of Hematology · 48 citations
https://doi.org/10.1002/ajh.26068
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
85
Citations
5
h-index
2
i10-index
Marie‐Charlotte Laude is an academic researcher from Inserm. The author has contributed to research in topics: CAR-T cell therapy research & Lymphoma Diagnosis and Treatment & CNS Lymphoma Diagnosis and Treatment. The author has an h-index of 5, co-authored 10 publications.
ORCID: 0000-0001-9967-706XClick to start Chat